Alzheimer's key visual

Diagnostic imaging solutions for the assessment of Alzheimer’s disease

Six million Americans are living with Alzheimer’s disease (AD) today and by 2050 this number is projected to rise to nearly 13 million.1 The recent federal approval of a groundbreaking Alzheimer’s treatment is the first directed at the underlying pathophysiology of Alzheimer’s disease, the presence of amyloid beta plaques in the brain.

Benefit from a comprehensive amyloid imaging solution by combining reliable PET radiopharmaceutical manufacturing and distribution of amyloid imaging agents with innovative hardware technologies and software for PET/CT imaging of amyloid plaques.

PETNET Solutions Inc., A Siemens Healthineers Company supports the growth of our customers' business with on-time delivery of PET tracers and comprehensive value-added services.

PETNET Solutions Inc. – A Siemens Healthineers Company – is the largest supplier for radiopharmaceuticals in the US, including amyloid imaging agents. PETNET Solutions, Inc., has 43 locations in the US and is delivering more than 1,000,000 doses to more than 2,800 imaging centers worldwide, each year.

Biograph Vision

Biograph PET/CT portfolio answers clinical needs to help clinicians diagnose, treat, and monitor disease more confidently. The Biograph Vision, for example, delivers high spatial resolution with high sensitivity providing sharp delineation of cerebral grey and white matter tracer uptake. LSO crystals combined with Time of Flight (TOF) technology provides improved image quality*, which can help make a quantifiable difference in the evaluation of amyloid plaque.

syngo.PET Amyloid Plaque

Quantitative guidance with syngo.via.PET amyloid plaque software – dedicated neurological quantification algorithms help to identify problems by comparing patient exams against a population database of normal, healthy brains and comparing exams over time.

A key component of the new approved therapy is managing any side effect that may arise; one known side effect is a condition called ARIA (Amyloid Related Imaging Abnormalities). MRI is the diagnostic tool of choice to diagnose ARIA. It is expected that this will require frequent and regular MRI scans to monitor any potential impact of ARIA over the course of treatment resulting in larger volume of MRI procedures. Experience MRI technologies that are designed to support this increased demand.

Biograph mMR

Biograph mMR PET/MR scanner provides simultaneous acquisition of co-registered MR and PET images with one examination. In the context of Alzheimer’s disease, the Biograph mMR can allow for PET’s use as an imaging biomarker while providing high-contrast, soft-tissue anatomical and functional brain images with MR.

AI-Rad Companion

AI-Rad Companion Brain MR software assistant brings value to the interpretation process via automatic segmentation and analysis of individual brain structures. The volume of each of these structures will be compared to a normative database and results will be offered in graphical as well as numerical values.

Siemens - MRI - Neurology - Screenshot Brain Dot Engine

Advanced MR Neuro Imaging solutions are designed to maximize MRI productivity in neuro imaging.

With increased MRI procedure volume, the need to reduce the stress on the MRI staff and more importantly reduce the time that the patient is on the exam table arises quickly. Benefit from solutions that can quickly make a positive impact to your customer’s workflow and the MR patient experience.

Embrace efficiency with GO technologies and Turbo Suite
With Turbo Suite technology, you can accelerate the entire MRI exam by up to 50%2 for all contrasts, orientations, and body regions. Essentially cutting MRI exam times in half.
Shaping next gen AI

Deep Resolve is an AI-powered image reconstruction technology that takes advantage of targeted denoising and convolutional neural networks to generate high resolution images from low resolution input. Scans can be faster, boosting workflow efficiency while improving patient comfort.

Complete the form below to talk to an expert about our Diagnostic Imaging Solutions for the assesment of Alzheimer's Disease


By clicking Submit you consent to the processing of your above given personal data by the Siemens Healthineers company referred to under Corporate Information and for the purpose described above. Further information concerning the processing of your data can be found in the Data Privacy Policy. You are aware that you can partially or completely revoke this consent at any time for the future. Please declare your revocation to the contact address given in the Corporate Information and sent it to us via the following e-mail address: